Pathologist-level interpretable whole-slide cancer diagnosis with deep learning

…, M Bui, Y Xie, M Sapkota, L Cui, J Dhillon… - Nature Machine …, 2019 - nature.com
Diagnostic pathology is the foundation and gold standard for identifying carcinomas. However,
high inter-observer variability substantially affects productivity in routine pathology and is …

Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change

J Dhillon, MB Amin, E Selbs, GK Turi… - The American journal …, 2009 - journals.lww.com
Sarcomatoid change has been well documented in the various subtypes of renal cell
carcinoma (RCC) and its presence is known to portend a worse prognosis in RCC. Mucinous …

[HTML][HTML] Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer

…, M Robertson-Tessi, R Bravo, J Dhillon… - British journal of …, 2019 - nature.com
Background Tumours rapidly ferment glucose to lactic acid even in the presence of oxygen,
and coupling high glycolysis with poor perfusion leads to extracellular acidification. We …

Urachal carcinoma: a pathologic and clinical study of 46 cases

J Dhillon, Y Liang, AM Kamat, A Siefker-Radtke… - Human pathology, 2015 - Elsevier
Urachal carcinoma is a rare tumor that has not been well studied. To determine the pathologic
and clinical features of this disease, we retrospectively evaluated 46 cases from our …

Macrophage-derived cholesterol contributes to therapeutic resistance in prostate cancer

…, A Keske, KLK Steiner, L Noel, AN Serna, J Dhillon… - Cancer research, 2021 - AACR
These results suggest that macrophage-targeted therapies can be combined with androgen
deprivation therapy to treat patients with prostate cancer by limiting cholesterol …

[HTML][HTML] Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer

K Sircar, H Huang, L Hu, D Cogdell, J Dhillon… - The American journal of …, 2012 - Elsevier
The identification of new and effective therapeutic targets for the lethal, castration-resistant
stage of prostate cancer (CRPC) has been challenging because of both the paucity of …

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

PE Spiess, J Dhillon, AS Baumgarten… - CA: A Cancer …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Squamous cell carcinoma (SCC) of the penis is a rare
malignancy in the United States, with a significantly higher incidence—up to 20 to 30 times …

[HTML][HTML] Case report: two cases of chemotherapy refractory metastatic penile squamous cell carcinoma with extreme durable response to pembrolizumab

…, WP Skelton IV, PE Spiess, C Walko, J Dhillon… - Frontiers in …, 2020 - frontiersin.org
Background Penile squamous cell carcinoma (PSCC) is a rare malignancy, and those patients
with metastatic disease have limited treatment options. Treatment is largely comprised of …

Genomic testing in localized prostate cancer can identify subsets of African Americans with aggressive disease

…, PAS Johnstone, J Pow-Sang, J Dhillon… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Personalized genomic classifiers have transformed the management of
prostate cancer (PCa) by identifying the most aggressive subsets of PCa. Nevertheless, the …

Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes

J Dhillon, NM Tannir, SF Matin, P Tamboli, BA Czerniak… - Human pathology, 2011 - Elsevier
Thyroid-like follicular carcinoma of the kidney is an extremely rare variant of renal cell
carcinoma. Most previously reported cases presented as incidental small tumors confined to the …